Corpuls | Investments | Nordic Capital
HEMS With Corpuls 3 Being Roped Off (1)

Corpuls

Innovative MedTech Products and Solutions

corpuls is a leading provider of high-quality and innovative products for professional users in emergency situations. The Company sells its products in more than 60 countries with a particular focus on portable defibrillator and monitoring systems as well as devices for mechanical chest compression and corresponding software solutions.

An impressive product portfolio and pronounced R&D capabilities have turned corpuls into one of Germany’s fastest growing mid-market companies.

Company Background

  • Founded in 1982 and has since been headquartered in Kaufering, Germany.
  • Develops a range of medical products and solutions, including advanced life-support defibrillators and monitoring devices, automated external defibrillators, chest compression devices, and telemedicine and software solutions. The products are designed to support professional users delivering critical care to patients under demanding circumstances.
  • Sells its products in more than 60 countries and was in 2022 recognised as the fastest-growing SME in Germany with an annual revenue growth rate of 26.5 percent between 2017 and 2021.

Vision & Outlook

  • Support corpuls' continued international growth trajectory in close partnership with the founding family and the management team.
  • Further invest in innovation, expand its telemedicine offering, accelerate its growth in the hospital segment and around the world.
  • Support sustainable growth and work innovatively on top-quality products that can save lives.
GS Corpuls 4C

SECTOR

Healthcare

REVENUES 2022

EUR 127 million

EMPLOYEES

450

OWNERSHIP

Fund XI

INVESTMENT DATE

2023

HEAD OFFICE

Kaufering, Germany

MANAGEMENT

Christian Klimmer

CEO

Iris Klimmer

CFO

Klaus Stemple

CTO

RESPONSIBLE ADVISOR

Jonas Agnblad

Partner, Co-Head of Evolution advisory

Nordic Capital's healthcare focus

Nordic Capital is one of the most active and experienced investors in healthcare globally, focusing on investments in companies throughout the healthcare space with potential to grow and expand into new markets and industry-leading innovations or value propositions.

Learn more here: